Navigation Links
PMSI Advocacy Efforts Prompt CMS to Improve MSA Review Methodology
Date:5/17/2010

PMSI Settlement Solutions, a leading provider of solutions for the workers' compensation and liability markets, announced that it has received notification from the Centers for Medicare and Medicaid Services (CMS) of new prescription drug requirements pertaining to Medicare Set-Asides (MSA).

Tampa, Florida (Vocus) May 17, 2010 -- PMSI Settlement Solutions, a leading provider of solutions for the workers' compensation and liability markets, announced that it has received notification from the Centers for Medicare and Medicaid Services (CMS) of new prescription drug requirements pertaining to Medicare Set-Asides (MSA). In a memorandum dated May 14th, CMS states that "For a Part D drug to be covered by Medicare, and thus included properly in a WCMSA, the drug should be prescribed for an outpatient use that is approved under the Federal Food, Drug, and Cosmetic Act [21 U.S.C.A. Sec. 301 et seq.”.

This recent memorandum clarifies the exclusion of non-Medicare Part D covered prescription drugs from MSA calculations. Eileen Auen, PMSI's Chief Executive Officer stated, "Over the past ten years, rising prescription drug costs have been an industry wide issue. As the only significant MSA provider with extensive pharmacy experience, PMSI was uniquely qualified to work with CMS on this important issue. CMS' improved approach will help to drive allocations back to acceptable amounts and prevent inflated MSAs.”

"Pain management medications are a very significant cost driver in workers' compensation. Many of the medications commonly utilized for the treatment of chronic pain are not covered by Part D," commented Kent Takemoto, M.D., President, PMSI Settlement Solutions. "In recent PMSI analysis, the exclusion of non-Part D covered drugs affected about 65% of the most commonly used drugs in workers' compensation.”

In anticipation of CMS' policy memorandum, PMSI developed a methodology for prescription drug calculations based on its 34 years of experience as one of the largest providers of Pharmacy Benefit Management (PBM) services to the workers' compensation industry. PMSI's methodology incorporates the company's knowledge of occupational diagnoses, the treatment of pain management and the selection of replacement drugs for non-Part D covered prescriptions. In use for over nine months, this methodology reduced a MSA by $935,000 in one recent client case.

Takemoto continued, "PMSI applauds CMS for clarifying this important issue. We have valued the opportunity to meet with CMS numerous times over the past year and look forward to continuing our active dialogue with CMS on further refinement of the MSA drug review process and other issues impacting Medicare Set-Aside allocations.”

About PMSI Settlement Solutions:
PMSI Settlement Solutions is recognized as a pioneer in Medicare Set-Aside allocations. PMSI Settlement Solutions offers a comprehensive menu of services for workers' compensation and liability/no-fault auto claims that are focused on settling claims in the most timely, cost-effective manner and in compliance with all government requirements. On-staff specialists are experts in lien negotiations, future medical cost projections and allocation preparation for cases in workers' compensation and liability. PMSI Settlement Solutions is a division of PMSI, one of the nation's largest providers of specialty managed care services and products for workers' compensation and liability markets. To learn more about PMSI Settlement Solutions, our services and web-enabled, integrated capabilities visit us at www.pmsisettlement.com or call us at 888.MSA.PMSI.

About PMSI:
PMSI is one of the nation's largest full-service providers of clinically driven services for Pharmacy, Medical Services and Equipment, and Settlement Solutions and is devoted exclusively to the workers' compensation and liability markets. For over 34 years, PMSI has led the industry and served as the trusted resource for thousands of insurance payers, state workers' compensation funds, employers, and third-party administrators. Today, PMSI continues its leadership position by managing millions of pharmacy, medical services and equipment, and settlement transactions each year. For more information, please refer to the PMSI website at www.pmsionline.com.

PMSI Contact:
Shelia Chapman
Executive Director, Marketing
877.ASK.PMSI

# # #

Read the full story at http://www.prweb.com/releases/PMSI/CMS/prweb4010834.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Veteran Advocacy Group to Announce New Program to Reform the VA
2. ASTRO awards 17 Advocacy Day travel grants
3. The Elizabeth Birt Center for Autism Law and Advocacy (EBCALA) Objects to Media Reports Tainting Autism Doctors and Misrepresenting Autism Treatments
4. Illinois State Senator Cullerton Recognized for Advocacy Work on Mental Health Issues
5. Father Channels His Grief into Advocacy, Promotes Simple Actions to Make Hospitals Safer for Children
6. Gladstones Robert Mahley to receive Research!America advocacy award
7. AT&T Connects Healthy Moms and Babies Nationwide, Embraces text4baby With Free Texts and Advocacy
8. Healthcare Partners, IPA, CEO Dr. Richard Merkin, Salute Enrollees Honored for Health Care Advocacy With Members of Congress
9. Protocol Q1 2010 Philanthropic Efforts a Resounding Success
10. NACDS Foundation Contributes $150,000 to Haiti Relief Efforts
11. Founder of the LEAP Foundation to be Honored for Haiti Aid Efforts at The Aesthetic Meeting 2010
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
PMSI Advocacy Efforts Prompt CMS to Improve MSA Review Methodology 
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
(Date:6/24/2016)... ... 2016 , ... Those who have experienced traumatic events may suffer from a ... such as drug or alcohol abuse, as a coping mechanism. To avoid this pain ... following a traumatic event. , Trauma sufferers tend to feel a range of emotions, ...
(Date:6/24/2016)... ... , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys ... peers for this recognition are considered among the top 2 percent of lawyers practicing ... members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are ... Code Talker Award, an essay contest in which patients and their families pay tribute ... presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016 Research and Markets has announced ... Diagnostic Tests" report to their offering. ... The World Market for Companion Diagnostics covers ... Market analysis in the report includes the following: ... Diagnostic Kits) by Region (N. America, EU, ROW), 2015-2020 ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
(Date:6/23/2016)... -- Research and Markets has announced the ... (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, ... Global Forecast to 2021" report to their offering. ... pharmaceutical excipients market is projected to reach USD 8.1 ... the forecast period 2016 to 2021. ...
Breaking Medicine Technology: